幼児の栄養と糖尿病について

Reframing our data: promoting positive epidemiology.

Perspectives in public health·2026

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.

Arteriosclerosis, thrombosis, and vascular biology·2002

Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis.

Thrombosis and haemostasis·1997

Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography.

Diabetes·1995

Prompting the clinical care of non-insulin dependent (type II) diabetic patients in an inner city area: one model of community care.

BMJ (Clinical research ed.)·1993

Diet as a source of phospholipid esterified 9,11-octadecadienoic acid in humans.

Clinical science (London, England : 1979)·1992

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Effects of Synbiotic Supplementation on Bone Turnover Markers in Kidney Transplant Recipients: A Randomized Controlled Trial.

Food science & nutrition·2026

Partial enteral nutrition combined with an exclusion diet promotes a healthy gut microbiome in patients with mild to moderately active ulcerative colitis: a quasi-experimental study.

Crohn's & colitis 360·2026

Severe Tertiary Hyperparathyroidism with Brown Tumor and Multisystem Complications Mimicking Plasma Cell Dyscrasia in a Middle-Aged Man with Childhood-Onset FSGS.

Journal of investigative medicine high impact case reports·2026

Refeeding syndrome: Applicability of ASPEN criteria in patients with intestinal failure.

Intestinal Failure (New York, N.Y.)·2026

Case series of selenium insufficiency among infants with intestinal failure.

Intestinal Failure (New York, N.Y.)·2026

Individual Amino Acid Supplementation Does Not Enhance Short-Term Proliferation of Selected Cancer Cell Lines In Vitro: Potential Implications for Nutritional Support in Cancer Cachexia.

Nutrients·2026

関連する実験動画

幼児の栄養と糖尿病について

関連する概念動画

Reframing our data: promoting positive epidemiology.

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.

Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis.

Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography.

Prompting the clinical care of non-insulin dependent (type II) diabetic patients in an inner city area: one model of community care.

Diet as a source of phospholipid esterified 9,11-octadecadienoic acid in humans.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Effects of Synbiotic Supplementation on Bone Turnover Markers in Kidney Transplant Recipients: A Randomized Controlled Trial.

Partial enteral nutrition combined with an exclusion diet promotes a healthy gut microbiome in patients with mild to moderately active ulcerative colitis: a quasi-experimental study.

Severe Tertiary Hyperparathyroidism with Brown Tumor and Multisystem Complications Mimicking Plasma Cell Dyscrasia in a Middle-Aged Man with Childhood-Onset FSGS.

Refeeding syndrome: Applicability of ASPEN criteria in patients with intestinal failure.

Case series of selenium insufficiency among infants with intestinal failure.

Individual Amino Acid Supplementation Does Not Enhance Short-Term Proliferation of Selected Cancer Cell Lines In Vitro: Potential Implications for Nutritional Support in Cancer Cachexia.

関連する実験動画

幼児の栄養と糖尿病について

関連する概念動画

関連記事